Lexaria Bioscience: Exciting Drug Delivery Technology Has Potential to Disrupt Multiple Categories; Add Long Term Shareholder Value

Lexaria Bioscience's powerful, proprietary drug delivery technology, DehydraTECH has the potential to disrupt multiple categories as the company continues to receive positive results from clinical... | June 7, 2023

Related Keywords

United States ,Chris Bunka ,Digital Holdings ,Advisory Inc ,Lexaria Bioscience ,Chief Executive Officer ,Investigational New Drug ,Lexaria Bioscience Corp Stock Exchange ,News ,Information ,Press Release ,Lexaria ,Roprietary ,Drug ,Delivery ,Dehydratech ,Gas ,The ,Potential ,O ,Isrupt ,Multiple ,Categories ,Us ,Company ,Ontinues ,Eceive ,Positive ,Results ,Rom Lexx Us52886n4060 ,